Erbitux

Product: ERBITUX

Manufacturer: BRISTOL MYERS SQUIBB

Generic: Cetuximab Injection

Type: Injection

Strength: Erbitux 100 mg (2 mg / ml) Injection

Packing: Injection Vial

Description: It is used to treat colo rectal cancer and cancer of head and neck. It is known as an anticancer medicine that is used alone in a combination with other medicines.

Indication: Colon, Rectal, Head and Neck Cancer

Use of Erbitux Injection

This infusion is a monoclonal antibody that specifically binds to receptors on cancer cells. It is an infusion used to treat head, neck and cancer of colon and rectum.

Side Effects of the Erbitux Injection

Major & minor side effects for Erbitux Injection

• Nausea
• Headache
• Vomiting
• Conjunctivitis
• Skin rash
• Diarrhea
• Infusion reaction
• Decreased magnesium level in blood
• Increased liver enzymes

When not to use?

This injection is not suggested for use in patients with a known allergy to Cetuximab or any other inactive ingredients present along with it.

Warning

• Pregnancy

It is unsafe to give it to pregnant women. Please seek the advice of doctor for further info.

• Breast-feeding

It is unsafe to use during breast-feeding, the drug may cause toxicity to the baby.

• Alcohol

Contact with alcohol is mysterious. Please seek advice from your doctor.

• Driving or operating machinery

Do not drive or operate machine unless you are feeling well, and Infusion may cause side effects which could affect your ability to drive or operate machine.

• Kidney

There is no data available. Please seek advice from doctor before consuming the drug.

• Liver

There is no data available. Please seek advice from doctor before consuming the drug.